SCHEMBL3310322

SCHEMBL3310322

C1=COCCC1.C1CCCCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9398 0.97
Fluoride SCHEMBL28168198 0.97
SCHEMBL16007902 0.97
SCHEMBL4906344 0.97
SCHEMBL28850452 0.94
Lithium SCHEMBL11159391 0.94
SCHEMBL28300924 0.94
Water SCHEMBL1602456 0.94
SCHEMBL10363928 0.94
Hydrochloric Acid SCHEMBL27300709 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183395-B2 Compositions and methods for treating cancer RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-05-22 US disclosed
US-20100113585-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER RUTGERS, THE STATE UNIVERSITY (US) 2010-05-06 US disclosed
WO-2008109717-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2008-09-12 WO disclosed